Rob Koremans, CEO of Italian pharmaceutical company Recordati, weighs in on the company's purchase of Sanofi's rare immune ...

Sanofi's Chief Digital Officer Emmanuel Frenehard had a thought that he just couldn't shake: how can Sanofi extend the ...

With several high-profile manufacturing outlays already in the books in Europe this year, Sanofi is returning to the bloc in ...

Sanofi, a leading global healthcare company, has received the “Corporate Social Impact Award 2024 – Gold level” for the fifth ...

Sanofi SNY and partner Regeneron REGN announced that the FDA has accepted their resubmitted supplemental biologics license ...

November is Diabetes Awareness Month; it’s a disease that affects millions of people across the United States – both with ...

An AI tool called Muse aims to optimize clinical trial patient recruitment and accelerate the development of new therapies.

One of the primary challenges in the regulatory affairs of the pharmaceutical industry is keeping pace with the ever-evolving regulatory landscape.

“There’s no rhyme or reason other than they just want to make more profit.” Companies like Eli Lilly, Novo Nordisk, Sanofi-Aventis and CVS are listed on the lawsuit. In a statement to WREG, Lilly ...

Zucara Therapeutics Inc., a diabetes life sciences company developing ZT-01, the first once-daily therapeutic to prevent hypoglycemia (low blood glucose levels) in people with diabetes, announced that ...

Left atrial appendage closure is an alternative strategy for stroke prophylaxis, Wazni and colleagues noted. "The safety and ...

CHICAGO -- Electronic nudges increased uptake of flu vaccines among patients with a history of acute myocardial infarction ...